[PDF][PDF] A COMPREHENSIVE REVIEW ON CANDESARTAN CILEXETIL: PHARMACOLOGICAL, PHARMACEUTICAL AND ANALYTICAL PROFILE

PS Krishna, MM Eswarudu, NS Priya, T Likhitha… - researchgate.net
Candesartan cilexetil is a pharmacological compound belonging to the class of angiotensin
II receptor blockers (ARBs), which are widely used in the management of cardiovascular …

Candesartan cilexetil: an update

A Joost, H Schunkert, PW Radke - Expert Opinion on …, 2011 - Taylor & Francis
Introduction: Candesartan cilexetil is one of the most often-used first-line drugs regarding the
management of arterial hypertension. Moreover, this drug has proven its effectiveness in …

[PDF][PDF] Analytical method development and validation for Candesartan Cilexetil as bulk drug and in pharmaceutical dosage forms by HPLC

V Kamalakkannan, A Puratchikody… - Der Pharmacia …, 2011 - researchgate.net
ABSTRACT A simple, sensitive and inexpensive isocratic reverse-phase liquid
chromatographic method has been developed for quantitative determination of Candesartan …

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

R Cernes, M Mashavi, R Zimlichman - Vascular Health and Risk …, 2011 - Taylor & Francis
The advantages of blood pressure (BP) control on the risks of heart failure and stroke are
well established. The renin-angiotensin system plays an important role in volume …

Candesartan cilexetil in cardiovascular disease

A Ross, V Papademetriou - Expert Review of Cardiovascular …, 2004 - Taylor & Francis
Hypertension is a major cardiovascular risk factor, but most patients remain asymptomatic
for many years. Successful therapy not only needs to be effective, it also needs to be well …

Clinical efficacy and tolerability of candesartan cilexetil

T Ogihara, K Arakawa - Journal of human hypertension, 1999 - nature.com
Clinical trials of candesartan cilexetil conducted in Japan are reviewed. Candesartan
cilexetil inhibited the pressor response to intravenous angiotensin II in healthy volunteers …

[PDF][PDF] A review on candesartan: pharmacological and pharmaceutical profile

A Husain, MS Azim, M Mitra… - Journal of Applied …, 2011 - japsonline.com
Candesartan is classified as an angiotensin II receptor type 1 antagonist. Angiotensin II
receptor type 1 antagonists are widely used in treatment of diseases like hypertension, heart …

Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil

PS Sever - Journal of Hypertension, 1997 - journals.lww.com
Conclusions Effective and sustainable blood pressure control in patients with essential
hypertension can be achieved with candesartan cilexetil in doses of 8 or 16 mg once a day …

Candesartan cilexetil: a review of its use in essential hypertension

KJ McClellan, KL Goa - Drugs, 1998 - Springer
Candesartan cilexetil is completely converted to the nonpeptide angiotensin II receptor
blocker candesartan during absorption from the gastrointestinal tract. Candesartan …

[PDF][PDF] Evaluation of gender difference in pharmacokinetics of Candesartan cilexetil in the fasted state by RP-HPLC: A single dose comparative study

HA Nawaz, MI Masood, M Abbas, M Usman… - Pakistan journal of …, 2019 - academia.edu
To compare the pharmacokinetics of candesartan cilexetil in healthy male and female
volunteers in order to identify possible influence of gender and to improve therapeutic …